Clinical Trial Update: PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma

View source ↗

Summary

This clinical trial evaluated PET-CT for managing patients with stage III or IV metastatic melanoma and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Melanoma | Status: COMPLETED